These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27941022)

  • 1. Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).
    Ulbricht D; Oertwig K; Arnsburg K; Saalbach A; Pippel J; Sträter N; Heiker JT
    J Biol Chem; 2017 Jan; 292(3):994-1004. PubMed ID: 27941022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane Phospholipids and Polyphosphates as Cofactors and Binding Molecules of SERPINA12 (vaspin).
    Tindall CA; Dommel S; Riedl V; Ulbricht D; Hanke S; Sträter N; Heiker JT
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin).
    Ulbricht D; Pippel J; Schultz S; Meier R; Sträter N; Heiker JT
    Biochem J; 2015 Sep; 470(3):357-67. PubMed ID: 26199422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of human vaspin (SERPINA12) and its impact on serpin activity, heparin binding and thermal stability.
    Oertwig K; Ulbricht D; Hanke S; Pippel J; Bellmann-Sickert K; Sträter N; Heiker JT
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1188-1194. PubMed ID: 28668641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.
    Ulbricht D; Tindall CA; Oertwig K; Hanke S; Sträter N; Heiker JT
    Biol Chem; 2018 Sep; 399(9):1079-1084. PubMed ID: 29494334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
    Alberdi E; Hyde CC; Becerra SP
    Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein.
    Chen VC; Chao L; Chao J
    J Biol Chem; 2000 Dec; 275(51):40371-7. PubMed ID: 10991942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaspin inhibits kallikrein 7 by serpin mechanism.
    Heiker JT; Klöting N; Kovacs P; Kuettner EB; Sträter N; Schultz S; Kern M; Stumvoll M; Blüher M; Beck-Sickinger AG
    Cell Mol Life Sci; 2013 Jul; 70(14):2569-83. PubMed ID: 23370777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site.
    Becerra SP; Perez-Mediavilla LA; Weldon JE; Locatelli-Hoops S; Senanayake P; Notari L; Notario V; Hollyfield JG
    J Biol Chem; 2008 Nov; 283(48):33310-20. PubMed ID: 18805795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of cleaved vaspin (serpinA12).
    Pippel J; Kuettner EB; Ulbricht D; Daberger J; Schultz S; Heiker JT; Sträter N
    Biol Chem; 2016 Jan; 397(2):111-23. PubMed ID: 26529565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a major heparin-binding site in kallistatin.
    Chen VC; Chao L; Pimenta DC; Bledsoe G; Juliano L; Chao J
    J Biol Chem; 2001 Jan; 276(2):1276-84. PubMed ID: 11016932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions.
    Chan ED; King PT; Bai X; Schoffstall AM; Sandhaus RA; Buckle AM
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
    Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
    Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to measure the kinetics of protease inhibition by serpins.
    Horvath AJ; Lu BG; Pike RN; Bottomley SP
    Methods Enzymol; 2011; 501():223-35. PubMed ID: 22078537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
    Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
    Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion.
    Ma L; Wu J; Zheng Y; Shu Z; Wei Z; Sun Y; Carrell RW; Zhou A
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32481593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.